About the University of Minnesota School of Public Health (SPH)
The School of Public Health (SPH) is one of the premier schools of public health in the world. For more than 80 years, SPH has trained some of the most influential leaders in the field, informing and transforming the way public health is practiced. The school is recognized for its excellence in research and education and for advancing policies and practices that both create and sustain health equity for all. SPH academic programs include 15 masters programs, four doctoral programs, and a newly established undergraduate program. SPH is also a leader in public health scholarship and discovery with $95 million in research funding in fiscal year 2024. SPH holds the highest level of research funding per faculty member at the University. SPH sits within a constellation of academic and clinical health sciences schools at the University of Minnesota, which is the third largest and most comprehensive public land-grant university and one of only a few located in a major metropolitan area. The Universitys infrastructure of six health sciences schools (Public Health, Dentistry, Medicine, Nursing, Pharmacy, and Veterinary Medicine)one of four of such models in the countrygives students, faculty, and staff many opportunities to collaborate and think boldly and broadly about leveraging all our disciplines to improve the health of populations. SPH researchers and educators also collaborate with UMN schools and colleges including the Humphrey School of Public Affairs, the College of Science and Engineering, the College of Liberal Arts, and the College of Food, Agricultural and Natural Resource Sciences. Health departments, communities, and policymakers collaborate with SPH faculty and staff to provide the information and guidance needed to make the best and most informed decisions about population health.
About the Division of Environmental Health Science
The Division of Environmental Health Sciences (EnHS) improves the health of individuals and communities by conducting rigorous and collaborative research to identify risks, reduce hazards, and inform public health policies, and by providing outstanding interdisciplinary education to prepare future environmental health practitioners and leaders. EnHS has 26 faculty with expertise in infectious and non-infectious disease, epidemiology, exposure science, toxicology, injury and violence prevention, and health impacts of climate change in community and workplace settings. Several specialty centers are housed in or closely affiliated with the division, including the Upper Midwest Agricultural Safety and Health Center, the Midwest Center for Occupational Health and Safety, the Mni Sota Center for Climate Change and Health, the Minnesota Food Safety Center of Excellence, the Masonic Cancer Center, and the Midwest Consortium for Hazardous Waste Worker Training. The division offers MPH, MS, and PhD degrees that allow students to specialize in a range of subjects.
About CIDRAP
The mission of the Center for Infectious Disease Research and Policy (CIDRAP), which is part of the Research and Innovation Office (RIO), is to prevent illness and death from targeted infectious disease threats through research and the translation of scientific information into real-world, practical applications, policies, and solutions. CIDRAP addresses a variety of international and national public health policy issues related to the prevention and control of infectious diseases through various projects, including vaccines and vaccine-preventable diseases; emerging infectious disease threats; development of R&D roadmaps for vaccines, diagnostics, and therapeutics for pathogens with epidemic potential; antimicrobial resistance and stewardship; chronic wasting disease; and epidemic emergency preparedness. CIDRAP has a strong Web and communication presence through the CIDRAP website, CIDRAP daily newsletters, podcasts, and webinars. National and international experts alike turn to CIDRAP for the latest information on COVID-19, influenza, One Health and other crucial emerging infectious diseases.